The ABCD of Obesity: An EASO Position Statement on a Diagnostic Term with Clinical and Scientific Implications
- PMID: 30844811
- PMCID: PMC6547280
- DOI: 10.1159/000497124
The ABCD of Obesity: An EASO Position Statement on a Diagnostic Term with Clinical and Scientific Implications
Abstract
Obesity is a frequent, serious, complex, relapsing, and chronic disease process that represents a major public health problem. The coining of obesity as an adiposity-based chronic disease (ABCD) is of particular relevance being in line with EASO's proposal to improve the International Classification of Diseases ICD-11 diagnostic criteria for obesity based on three dimensions, namely etiology, degree of adiposity, and health risks. The body mass index as a unique measurement of obesity does not reflect the whole complexity of the disease. Obesity complications are mainly determined by 2 pathological processes, i.e., physical forces (fat mass disease) as well as endocrine and immune responses (sick fat disease), which are embedded in a cultural and physical context leading to a specific ABCD stage.
Keywords: Adiposity; Comorbidities; Dysfunctional adipose tissue; Noncommunicable diseases.
© 2019 The Author(s) Published by S. Karger AG, Basel.
Figures

Similar articles
-
Proposal for a Scientifically Correct and Medically Actionable Disease Classification System (ICD) for Obesity.Obesity (Silver Spring). 2020 Mar;28(3):484-492. doi: 10.1002/oby.22727. Obesity (Silver Spring). 2020. PMID: 32090513 Free PMC article. Review.
-
A Proposal of the European Association for the Study of Obesity to Improve the ICD-11 Diagnostic Criteria for Obesity Based on the Three Dimensions Etiology, Degree of Adiposity and Health Risk.Obes Facts. 2017;10(4):284-307. doi: 10.1159/000479208. Epub 2017 Jul 22. Obes Facts. 2017. PMID: 28738325 Free PMC article.
-
ADIPOSITY-BASED CHRONIC DISEASE AS A NEW DIAGNOSTIC TERM: THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT.Endocr Pract. 2017 Mar;23(3):372-378. doi: 10.4158/EP161688.PS. Epub 2016 Dec 14. Endocr Pract. 2017. PMID: 27967229
-
Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement.Clin Nutr. 2022 Apr;41(4):990-1000. doi: 10.1016/j.clnu.2021.11.014. Epub 2022 Feb 22. Clin Nutr. 2022. PMID: 35227529
-
Visceral adiposity and inflammatory bowel disease.Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
Cited by
-
Obesity and COVID-19: The Two Sides of the Coin.Obes Facts. 2020;13(4):430-438. doi: 10.1159/000510005. Epub 2020 Jul 13. Obes Facts. 2020. PMID: 32659766 Free PMC article.
-
Proposal for a Scientifically Correct and Medically Actionable Disease Classification System (ICD) for Obesity.Obesity (Silver Spring). 2020 Mar;28(3):484-492. doi: 10.1002/oby.22727. Obesity (Silver Spring). 2020. PMID: 32090513 Free PMC article. Review.
-
The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits.Nat Rev Endocrinol. 2022 Oct;18(10):623-637. doi: 10.1038/s41574-022-00716-0. Epub 2022 Jul 28. Nat Rev Endocrinol. 2022. PMID: 35902734 Free PMC article. Review.
-
Explaining adult obesity, severe obesity, and BMI: Five decades of change.Heliyon. 2023 May 19;9(5):e16210. doi: 10.1016/j.heliyon.2023.e16210. eCollection 2023 May. Heliyon. 2023. PMID: 37251838 Free PMC article.
-
Healthcare professionals' perceptions and management of obesity & knowledge of glucagon, GLP-1, GIP receptor agonists, and dual agonists.Obes Sci Pract. 2024 May 4;10(3):e756. doi: 10.1002/osp4.756. eCollection 2024 Jun. Obes Sci Pract. 2024. PMID: 38708040 Free PMC article.
References
-
- Frühbeck G, Gómez-Ambrosi J. Control of body weight: a physiologic and transgenic perspective. Diabetologia. 2003 Feb;46((2)):143–72. - PubMed
-
- Gluckman PD, Hanson M, Zimmet P, Forrester T. Losing the war against obesity: the need for a developmental perspective. Sci Transl Med. 2011 Jul;3((93)):93cm19. - PubMed
-
- Frühbeck G, Toplak H, Woodward E, Yumuk V, Maislos M, Oppert JM, Executive Committee of the European Association for the Study of Obesity Obesity: the gateway to ill health - an EASO position statement on a rising public health, clinical and scientific challenge in Europe. Obes Facts. 2013;6((2)):117–20. - PMC - PubMed